[CH:1](=[O:4])[CH2:2][CH3:3].[Br:5][C:6]1[CH:11]=[CH:10][C:9](/[CH:12]=[CH:13]/[N+:14]([O-:16])=[O:15])=[CH:8][CH:7]=1.CC(O)C.CCCCCC>C(Cl)(Cl)Cl>[Br:5][C:6]1[CH:7]=[CH:8][C:9]([C@H:12]([CH2:13][N+:14]([O-:16])=[O:15])[C@H:2]([CH3:3])[CH:1]=[O:4])=[CH:10][CH:11]=1The title compound was prepared from propionaldehyde and (E)-1-bromo-4-(2-nitrovinyl)benzene according to the general procedure. Both enantiomeric excess and diastereomeric ratio were determined by HPLC with an AD-H column at 230 nm (2-propanol:hexane=5:95), 1.0 mL/min; major enantiomer tmajor=18.59 min, tminor=13.77 min. [α]D20=−24.6 (c=2.1, CHCl3).